On this page, EB-ResNet provides information on external funding possibilities. We do not intend to give a complete overview of funding possibilities but display interesting calls and information about other funding sources relevant for persons involved in EB research.
Upcoming and current external calls
INNOVATIVE MEDICINES INITIATIVE: IMI-2 - Call 20
"Research Projects on Personalised Medicine - Pre-/Clinical research, Big Data and ICT, Implementaion and User's Perspective"
AFM TELETHON supports research into gene and/or cell therapy of rare disorders, through Postdoctoral Fellowships, PhD Fellowships and Research grants.
An annual International Call for Proposals is open to both French and foreign teams:
Call: "Development of therapeutic approaches for rare genetic diseases."
1 Gene and/or cell therapy for rare genetic disorders
Breakthrough innovation
Gene transfer and gene correction
Genome editing
Genetically modified cells
Development of delivery strategies
Control of the immune response (auto-immunity, anti-vector and anti-transgene responses, etc.)
2 Strategies for modifying gene expression both at the gene and RNA level
Projects based on gene transfer, chemical molecules or biotherapies
For new applications for Research Grants, Trampoline Grants and Postdoctoral Fellowships (only students enrolled in a French university doctoral degree
Program are eligible):
Deadline for submission of applications: 21 January 2020.
Results: mid-July 2020.
For new applications for PhD fellowships:
Deadline for submission of applications: 7 April 2020
European Joint Programme on Rare Diseases (EJP RD) – Joint Transnational Call 2020
Call: “Pre-clinical research to develop effective therapies for rare diseases"
Aim
To build a collaboration (4-6 eligible principal investigator partners) on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear benefit for patients.
Topic
Development of novel therapies in a preclinical setting (including small molecules, repurposing drugs, cell and gene advanced therapies)
Use of disease models suitable for medicinal product’s development
Development of predictive and pharmacodynamics (PD) biomarkers in a preclinical setting
Proof of principle studies fostering an early (pre-clinical) stage of drug development
Submission deadlines Pre-proposal: 12 February 2020 Full proposal: 16 June 2020
This yearly funding opportunity supports novel and innovative basic, fundamental and translational research into prevention, diagnosis or treatment of cancer.
Restrictions: WWCR do NOT support clinical research, including clinical trials, patient care, nursing or healthcare delivery research, policy, public health or psychosocial research.
Submission deadline 7 April 2020
Budget
The maximum Budget is £250,000, however, most of the three-year grants awarded have a budget below £200,000.
Back to main navigation This website uses cookies to give you the best possible service. By using this website, you agree to the use of cookies. Detailed information can be found in our privacy policy .
